相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。In vitro and in vivo evaluation of possible pro-survival activities of PGE2, EGF, TPO and FLT3L on human hematopoiesis
Eva-Maria Demmerath et al.
HAEMATOLOGICA (2019)
Concise Review: Cheating Death for a Better Transplant
Sehar Afreen et al.
STEM CELLS (2018)
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Delphine Merino et al.
CANCER CELL (2018)
The BCL-2 arbiters of apoptosis and their growing role as cancer targets
Jerry M. Adams et al.
CELL DEATH AND DIFFERENTIATION (2018)
Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation
Matthias Kollek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The BH3-only proteins BIM and PUMA are not critical for the reticulocyte apoptosis caused by loss of the pro-survival protein BCL-XL
Alex R. D. Delbridge et al.
CELL DEATH & DISEASE (2017)
BCL-2 family: integrating stress responses at the ER to control cell demise
Philippe Pihan et al.
CELL DEATH AND DIFFERENTIATION (2017)
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Jianhui Chang et al.
NATURE MEDICINE (2016)
Bcl-2 proteins in development, health, and disease of the hematopoietic system
Matthias Kollek et al.
FEBS JOURNAL (2016)
Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-/- γc-/- mice
Christopher Felix Krombholz et al.
HAEMATOLOGICA (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-/- γc-/- mice
Christopher Felix Krombholz et al.
HAEMATOLOGICA (2016)
A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia
Thomas J. Kipps et al.
LEUKEMIA & LYMPHOMA (2015)
The proapoptotic BH3-only proteins Bim and Puma are downstream of endoplasmic reticulum and mitochondrial oxidative stress in pancreatic islets in response to glucotoxicity
J. A. Wali et al.
CELL DEATH & DISEASE (2014)
PUMA mediates ER stress-induced apoptosis in portal hypertensive gastropathy
S. Tan et al.
CELL DEATH & DISEASE (2014)
Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity
Zhi-Fu Tao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
BH3-only protein Noxa contributes to apoptotic control of stress-erythropoiesis
Felix M. Wensveen et al.
APOPTOSIS (2013)
Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf
Verena Labi et al.
EMBO MOLECULAR MEDICINE (2013)
Direct Interaction of Bax and Bak Proteins with Bcl-2 Homology Domain 3 (BH3)-only Proteins in Living Cells Revealed by Fluorescence Complementation
Laura Vela et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Bcl-x Inactivation in Macrophages Accelerates Progression of Advanced Atherosclerotic Lesions in Apoe-/- Mice
Andrew I. U. Shearn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Contrasting dynamic responses in vivo of the Bcl-xL and Bim erythropoietic survival pathways
Miroslav Koulnis et al.
BLOOD (2012)
Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML
Thanh-Trang Vo et al.
CELL (2012)
Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
Andrew W. Roberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Bcl-xL Retrotranslocates Bax from the Mitochondria into the Cytosol
Frank Edlich et al.
CELL (2011)
Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets
Emma C. Josefsson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Humanized Culture Medium for Clinical Expansion of Human Erythroblasts
Giovanni Migliaccio et al.
CELL TRANSPLANTATION (2010)
Of mice and men: Human RNA polymerase III promoter U6 is more efficient than its murine homologue for shRNA expression from a lentiviral vector in both human and murine progenitor cells
Roland Roelz et al.
EXPERIMENTAL HEMATOLOGY (2010)
Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells
Randolph M. Abutin et al.
EXPERIMENTAL HEMATOLOGY (2009)
Erythroid expansion and survival in response to acute anemia stress: The role of EPO receptor, GATA-1, Bcl-xL and caspase-3
Gualberto Rodrigo Aispuru et al.
CELL BIOLOGY INTERNATIONAL (2008)
Essential role for Nix in autophagic maturation of erythroid cells
Hector Sandoval et al.
NATURE (2008)
Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis
Abhinav Diwan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Programmed anuclear cell death delimits platelet life span
Kylie D. Mason et al.
CELL (2007)
Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells
JT Opferman et al.
SCIENCE (2005)
Molecular biology of erythropoietin
W Jelkmann
INTERNAL MEDICINE (2004)
The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation
W Aerbajinai et al.
BLOOD (2003)
Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins
A Zeuner et al.
BLOOD (2003)
Apoptosis protection by the Epo target Bcl-XL allows factor-independent differentiation of primary erythroblasts
H Dolznig et al.
CURRENT BIOLOGY (2002)
Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1low mice)
AM Vannucchi et al.
BLOOD (2001)
Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors
T Shinjyo et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)